This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2003-2011.
Company Filing History:
Years Active: 2003-2011
Title: John E Thornton: Innovator in Pharmaceutical Chemistry
Introduction
John E Thornton is a notable inventor based in Newtown, PA (US), recognized for his contributions to pharmaceutical chemistry. He holds a total of four patents, showcasing his innovative approach to drug development and treatment methodologies.
Latest Patents
Thornton's latest patents include the crystalline forms of [(1R), 2S]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester. This invention provides a pharmaceutical composition and an oral dosage form comprising the Form N-1 of Compound I, which has been shown to be effective in the treatment of cancer and other proliferative diseases. Additionally, he has developed an improved process for preparing this compound, further enhancing its potential therapeutic applications.
Career Highlights
Throughout his career, Thornton has worked with prominent companies, including Bristol-Myers Squibb Company. His work has significantly impacted the field of pharmaceuticals, particularly in developing treatments for various types of cancer.
Collaborations
Thornton has collaborated with notable coworkers such as Wen Sen Li and Zhenrong Guo, contributing to the advancement of pharmaceutical innovations.
Conclusion
John E Thornton's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect a commitment to improving cancer treatment and advancing medical science.